Parkinson's diseaseCare homesAnti-parkinsonian medicationNinety-one patients were living in a care home and 286 in their own home.Levodopa equivalent dose (LED) was lower in care home than own home patients.Age, LED and disease stage were associated with care home residence.Disease duration did...
The effect of dopaminergic medication on speech has rarely been examined in early-stage Parkinson's disease (PD) and the respective literature is inconclusive and limited by inappropriate design with lack of PD control group. The study aims to examine the short-term effect of dopaminergic ...
The bidirectional longitudinal relationship between insomnia,depression and anxiety in patients with early-stage,medication-na?ve Parkinson’’s disease. Rutten S,Vriend C,Berendse HW,et al. Parkinsonism Related Disorder . 2017Rutten, S., Vriend, C., van der Werf, Y. D., Berendse, H. W.,...
A Type 2 diabetes medication called lixisenatide appeared to slow the progression of Parkinson’s disease symptoms in a small, mid-stage trial funded by the French Ministry of Health and others, the New England Journal of Medicine reported on Thursday. ...
Objective: To investigate whether impaired plantar cutaneous vibration perception contributes to axial motor symptoms in Parkinson’s disease (PD) and whether anti-parkinsonian medication and subthalamic nucleus deep brain stimulation (STN-DBS) show different effects. Methods: Three groups were evaluated: ...
Objective: To investigate whether impaired plantar cutaneous vibration perception contributes to axial motor symptoms in Parkinson’s disease (PD) and whether anti-parkinsonian medication and subthalamic nucleus deep brain stimulation (STN-DBS) show different effects. Methods: Three groups were evaluated: ...